Strengthening evidence for active surveillance for prostate cancer

European Urology

Volumn 63, Issue 1, 2013, Pages 108-110

  Klotz, Laurence ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SWEDEN; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84870539097     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.10.018     Document Type: Editorial

References (10)

1. R.A. Godtman, E. Holmberg, E. Khatami, J. Stranne, and J. Hugosson Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial Eur Urol 63 2013 101 107
2. T.J. Wilt, M.K. Brawer, K.M. Jones Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
3. A. Bill-Axelson, L. Holmberg, M. Ruutu SPCG-4 Investigators Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
4. L. Klotz, and I. Thompson Early prostate cancer - treat or watch? New Engl J Med 265 2011 569
5. M.F. O'Brien, A.M. Cronin, P.A. Fearn Trans-Atlantic Prostate Group Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively Int J Cancer 128 2011 2373 2381
6. A. Loblaw, L. Zhang, and A. Lam Comparing prostate specific antigen triggers for intervention in men with stable prostate cancer on active surveillance J Urol 184 2010 1942 1946
7. Y. Krakowsky, A. Loblaw, and L. Klotz Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics J Urol 184 2010 131 135
8. S.P. Porten, J.M. Whitson, J.E. Cowan, N. Perez, K. Shinohara, and P.R. Carroll Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer J Urol 186 2011 1825 1829
9. M. Auprich, A. Bjartell, and F.K.-H. Chun Contemporary role of prostate cancer antigen 3 in the management of prostate cancer Eur Urol 60 2011 1045 1054
10. Donovan M, Klotz L. Systems based biopsy model (Prostate Px+) identifies favorable risk prostate cancer in men on active surveillance. Paper presented at: American Urological Association annual meeting; May 2011; Washington, DC, USA.